[Skip to Navigation]
August 1949


Author Affiliations

Chief, Division of Tuberculosis Federal Security Agency Public Health Service Washington 25, D. C.

Am J Dis Child. 1949;78(2):280. doi:10.1001/archpedi.1949.02030050291014

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


To the Editor.—In the article, "BCG Vaccination in Chicago," by Dr. Robert A. Black in your journal of March, 1949 [p. 381] there appears the following statement, "At present, the Tice Laboratories have been designated as the central laboratories for BCG production for the United States Public Health Service." This letter is occasioned because this statement could easily be misinterpreted.

The Tice Laboratories have been one of the sources of the BCG used by the Public Health Service in research on the vaccine. However, the Public Health Service is also receiving BCG from the Pasteur Institute, Paris, State Serum Institute of Copenhagen, Division of Laboratories and Research of the New York State Department of Health, Albany, and the Pennsylvania Department of Health Laboratory at Henry Phipps Institute, Philadelphia. All of the aforementioned laboratories have been most cooperative and helpful. There is no officially designated central source of the vaccine.

First Page Preview View Large
First page PDF preview
First page PDF preview
Add or change institution